RAMP3 is a prognostic indicator of liver cancer and might reduce the adverse effect of TP53 mutation on survival

Future Oncol. 2018 Oct;14(25):2615-2625. doi: 10.2217/fon-2018-0296. Epub 2018 Jun 8.

Abstract

Aim: To assess the prognostic value of RAMP3 expression in terms of overall survival (OS) and recurrence-free survival (RFS) in hepatocellular carcinoma (HCC) patients.

Materials & methods: Immunochemistry staining was performed to detect RAMP3 expression. Data in the Cancer Genome Atlas-Liver Hepatocellular Cancer were used for secondary analysis.

Results: RAMP3 expression was significantly downregulated in HCC tissues than in normal liver tissues. Increased RAMP3 expression was an independent prognostic factor of favorable OS (hazard ratio [HR]: 0.772, 95% CI: 0.689-0.864; p < 0.001) and RFS (HR = 0.719, 95% CI: 0.633-0.817; p < 0.001). High RAMP3 expression was associated with significantly better RFS in both TP53 mutant and wildtype groups.

Conclusion: High RAMP3 RNA expression is an independent prognostic factor of favorable OS and RFS in patients with HCC.

Keywords: RAMP3; hepatocellular carcinoma; overall survival; recurrence-free survival.

MeSH terms

  • Adult
  • Aged
  • Carcinoma, Hepatocellular / chemistry
  • Carcinoma, Hepatocellular / genetics
  • Carcinoma, Hepatocellular / mortality*
  • DNA Methylation
  • Female
  • Humans
  • Liver / chemistry
  • Liver Neoplasms / chemistry
  • Liver Neoplasms / genetics
  • Liver Neoplasms / mortality*
  • Male
  • Middle Aged
  • Mutation*
  • Prognosis
  • Receptor Activity-Modifying Protein 3 / analysis
  • Receptor Activity-Modifying Protein 3 / genetics
  • Receptor Activity-Modifying Protein 3 / physiology*
  • Tumor Suppressor Protein p53 / genetics*

Substances

  • RAMP3 protein, human
  • Receptor Activity-Modifying Protein 3
  • TP53 protein, human
  • Tumor Suppressor Protein p53